Successful Placement of A$3M
October 10, 2024
Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The
Press & Media Coverage
Catch up on our latest press coverage
[Video] Shareholder Webinar Recording | August 15, 2024
August 22, 2024
Open a copy of this presentation deck from our ASX announcement HERE. Video transcript: Mel: Good morning, everyone. Thank you for attending the investor presentation
Imagion Biosystems Announces Shareholder Webinar
August 13, 2024
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, is pleased to invite you to join us
Imagion Appoints New Non-Executive Director, Brett Mitchell
June 15, 2024
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, today announced the appointment of Mr Brett Mitchell
[VIDEO] 2024 Annual General Meeting
June 3, 2024
Download a copy of the AGM 2024 presentation deck HERE. AGM 2024 Video Transcript: Good morning, ladies and gentlemen. My name is Robert Crew and
Quarterly Activity Report – Quarter ending 31 December 2023
January 31, 2024
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal
Watch our latest media coverage
Recent Press Coverage
14:13
4:13
4:09
4:19
16:09
5:26
7:30
16:30
18:44
3:10
4:41
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.